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Abstract
Rationale and Objectives—To compare the cancer detection rate and ROC area under the curve
of full-field digital mammography, screen-film mammography, and a combined technique that
allowed diagnosis if a finding was suspicious on film, on digital, or both.
Materials and Methods—We used the data originally analyzed in Lewin et al. (2002). In that
trial, 6,736 paired full-field and digital mammograms were performed in 4,489 women. We used
parametric and nonparametric tests to compare the area under the curve for ROC scores of film-
screen only, digital mammography only, and the combined test. We used McNemar’s test for paired
proportions to compare the cancer detection rates.
Results—With the parametric test, neither the difference in AUC between the film and combined,
nor the difference between the digital and combined ROC curves was significant at the Bonferroni-
corrected 0.025 alpha level (film vs. combined difference = 0.0563, p = 0.0712; digital vs. combined
difference = 0.0894, p = 0.0455). The nonparametric test showed that there was a significant
difference between both film and combined (difference = 0.073, p = 0.008) and digital vs. combined
ROC curves (difference = 0.1164, p = 0.0008). The continuity corrected McNemar’s test showed a
significant increase in the proportion of cancers detected by the combined modality over film (chi
squared = 7.111, df = 1, p=0.0077), and over digital (chi squared = 12.071, df =1, p = 0.0005).
Conclusion—Using two mammograms, one film and one digital, significantly increases the
detection of breast cancer.
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Three recent clinical trials with paired designs have compared full field digital and screen-film
mammography (1–3). Each woman was imaged with both digital and film machines. The
purpose of these trials was to compare the diagnostic accuracy of the digital and film
approaches. Interestingly, in each study, more cancers were detected than would have been
detected by either modality alone (Table 1). This suggests that full-field digital mammography
and screen film mammography could be used in tandem to improve breast cancer detection.
Although doing two different mammograms, with two different readers is burdensome and
costly, there is historical precedent for dramatically increasing the screening protocol. Sickles
et al. (4) demonstrated that doing both mediolateral oblique and craniocaudal views increased
cancer detection rates. He recommended always doing both views, which became the new
standard in the field. Although doing two views was twice as expensive and required much
more radiologist time, it allowed the detection of more cancers, which “outweigh(ed) the
additional radiation risk and added cost”.
We define a combined test as a test that declares a woman to have cancer if the cancer is detected
by film mammography alone, by digital mammography alone, or by both modalities. The ROC
score assigned is the maximum of the film and digital scores. We assume that a woman would
be recalled for a biopsy if either modality suggested follow-up work. We hypothesize that such
a combined test will give a larger area under the ROC curve (AUC) than either modality alone.
Additionally, we hypothesize that the total number of cancers detected by the combined test
will be significantly higher than the total number of cancers detected by either modality alone.
Materials and Methods
Lewin et al. (1) conducted a trial of 4,489 women, who received both full-field digital and
screen-film mammography. They analyzed the results of 6,736 paired examinations, and tested
the difference in area under the free response operating characteristic curve (5,6) for the two
modalities. We re-analyzed the same data in order to test our new hypotheses.
To conduct the ROC analysis we emulated the methodology of the Digital Mammographic
Imaging Screening Trial (DMIST). We used a parametric binormal ROC technique for paired
data (7) (www-radiology.uchicago.edu) for the primary analysis. A nonparametric AUC test
for paired data (8) was conducted as a planned confirmatory analysis. Both Hajian-Tilaki et
al. (9) and Zhou (10) point out that parametric and nonparametric methods produce roughly
the same result, without appreciable error or bias.
We used the continuity corrected McNemar’s test for paired nominal data (11) to compare the
proportion of cancers detected by the combined modality, versus either modality alone.
Because we are testing two hypotheses in both the ROC analysis and in the McNemar’s
analysis, (combined modality versus film, and combined modality versus digital) we controlled
for multiple comparisons. Thus, we tested each hypothesis at a Bonferroni corrected alpha level
of 0.025.
In the trial conducted by Lewin et al. (1), the radiologist produced an ROC score for each
finding seen on digital mammography, and a similar ROC score for each finding seen on film
mammography. There was no overall ROC score for the digital mammogram or the film
mammogram. For each exam, we took the overall maximum digital ROC score, the overall
maximum film ROC score, and the overall maximum combined ROC score. The overall
maximum combined ROC score provided a measure of how confident the radiologist was that
either modality had detected a malignancy. For the breasts which were proven to contain
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malignancy, we verified that the highest score actually was assigned to the finding that was
diagnosed as cancerous.
Lewin et al. (1) reported a total of 42 cancers diagnosed by mammography, 33 diagnosed on
film, 27 diagnosed on digital, 18 diagnosed by both, and 8 interval cancers. After a thorough
review of the data, we discovered that one patient was counted as having two cancers, in the
same quadrant of the same breast. Biopsy records show that there was one cancer. Therefore,
our analysis used a total of 41 cancers detected by mammography: 32 detected on film, 27
detected on digital, and 18 detected by both film screen and digital mammography.
Additionally, there were 8 interval cancers. The 8 interval cancers plus the 41 cancers detected
by mammography yielded a total of 49 cancers diagnosed in this study population.
Results
The primary analysis used the parametric binormal ROC technique (7). The difference between
the digital and film ROC curves was not significant (difference = 0.0418, p = 0.51), verifying
the results of Lewin et al. (1). The difference between the film and combined ROC curves was
also not significant at the Bonferroni-corrected 0.025 alpha level (difference = 0.0563, p =
0.0712), as was the difference between the digital and the combined curves (difference =
0.0894, p = 0.0455). (Figure 1 and Table 2)
Interestingly, the nonparametric tests (8) that were run to confirm the parametric tests showed
a significant difference between the film vs. combined ROC curves (difference = 0.073, p =
0.008) and digital vs. combined ROC curves (difference = 0.1164, p = 0.0008). As expected,
the nonparametric test of the film vs. the digital ROC curves was not significant (difference =
0.0434, 0.3863) (Figure 2 and Table 3).
Although the direction of the difference in AUC is the same in both the parametric and
nonparametric tests, the parametric p-values were not significant, while the nonparametric ones
were. The two types of tests will usually produce similar p-values. However, they use
estimation methods that are different enough that occasionally, one will be significant while
the other is not. The major theoretical reason why the areas under the curve are different is that
the parametric method used a binormal fit, while the non-parametric method used a trapezoidal
rule to estimate the area. Thus, the estimated operating points of the two methods have different
locations. In the presence of these conflicting results, a definite conclusion regarding the benefit
of the combined modality based on ROC curves cannot be drawn. Future studies would be
needed to confirm the ROC result.
Another approach to understanding the contribution of a combined testing approach is to focus
on the number of cancers detected. Screen film mammography detected 65.3% of the 49
cancers, full field digital mammography detected 55.1%, and the combined modalities detected
83.7% (Table 1). The continuity corrected McNemar’s test showed a significant increase in
the proportion of cancers detected by the combined modality over film (chi squared = 7.111,
df = 1, p=0.0077), and over digital (chi squared = 12.071, df =1, p = 0.0005). Again, the film
versus digital comparison showed no significant difference (chi squared = 0.696, df = 1, p =
0.4042).
Discussion
The increase in area under the curve for the combined modality reflects a larger increase in
sensitivity than the decrease in specificity. The ROC analysis is important, because it allows
researchers to look at the performance of diagnostic methods over the entire range of sensitivity.
However, for many women with breast cancer, whether their breast cancer is detected is the
most important factor in measuring the benefit of screening mammography. The McNemar’s
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tests directly address this issue, by comparing the proportion of cancers that were diagnosed
by each method.
In the Lewin trial (1), the detection rate of both modalities combined was higher than either
film mammography or digital mammography alone (Table 1). The number of cancers
diagnosed by combined modalities may have increased for any of three reasons: 1. Film-screen
mammography and full-field digital mammography detected different populations of cancers,
2. Four different views of each breast (cranial-caudal and mediolateral on both digital and film)
totaling four different compressions of each breast increased detection. 3. Independent reading
by two different radiologists increased detection.
Double reading of mammography has been shown to increase detection. The existing data on
double reading mostly comes from Europe. Anttinen et al. (12) looked at double reading in a
screening population of 17,000 women in Finland, and suggested that the double reading
increased cancer detection rates by 9%. Thurfjell et al. (13) conducted a study of double reading
in a Swedish population of more than 11,000 women and increased the number of cancers
detected by almost 15%. Ciatto et al. (14) evaluated the effect of a simulated double reading
technique in a highly enriched training set and found that that double reading improved
sensitivity from 50.2% to 64.8%.
If double reading accounts for only some of the observed increase in cancer detection, it seems
likely that increasing the number of views or using two different modalities was an additional
cause of the better performance. We believe that two clinical trials would be needed in order
to determine whether the number of compressions or the different modalities increased the
number of cancers detected. It cannot be determined which factor is responsible without
additional data collection.
Lewin et al. (1,Table 1) summarized the reasons why findings were only detected by one
modality. The most common reason cited was “fortuitous positioning”. For demonstration,
Lewin et al. (1,Figure 1) showed a mammogram in which a density is visible on a screen-film
mammogram due to overlapping tissue, but invisible on a digital mammogram due to different
positioning and compression. We suspect that in the Lewin trial (1), positioning and
compression differences affected the detection rate, but we cannot tell the proportion of
increase in detection that was due to this reason. The DMIST group is currently conducting an
analysis of their images to determine the extent that positioning and compression differences
or other factors affected the detection rate.
In fact, with the current clinical trial data, we cannot determine whether the number of readers,
the number of compressions, or the use of two different modalities is responsible for the
increased cancer detection rate. Lewin et al. (1) and Pisano et al. (3) did not intend to answer
these questions, or even to consider using two-modality mammography as a screening method.
In the section that follows, we describe the study designs that would be needed to answer these
questions. These studies have not been carried out, and are purely theoretical exercises designed
to demonstrate how one could differentiate between the proposed different causes of the
increased detection rate.
A three arm randomized controlled trial is the best way to test whether the two screening
modalities find different populations of cancer. The three arms would employ the following
screening modalities: arm one: two film mammograms; arm two: two digital mammograms;
arm three: one digital and one film mammogram. Each mammogram would include both
mediolateral oblique and craniocaudal views. Each mammogram would be read by one of two
readers, randomly chosen from a pool of qualified mammographers. A woman would be
recalled for a biopsy if either reader suggested follow-up work. This trial fixes the number of
readers (two), and the number of views (four). The only factor remaining is the modality.
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The following four arm clinical trial could test whether the number of compressions increases
the detection rate. The four arms would employ the following four different screening
modalities: arm one: two film mammograms; arm two: one film mammogram; arm three: two
digital mammograms; arm four: one digital mammogram. Each mammogram would include
two views (mediolateral oblique and craniocaudal), and two compressions. There would be
one reader for each exam, assigned at random from a pool of trained mammographers. We
would compare the single film mammogram arm to the double film mammogram, and the
single digital mammogram arm to the double digital mammogram arm. This trial fixes the
number of readers (one), and the modality (film or digital). The only factor left that could affect
the number of cancers detected is the number of views.
We speculate that using two different sorts of machines will improve cancer detection more
than increasing the number of views. In the DMIST trial, digital mammography had an
advantage in young women, pre-menopausal women, and women with dense breasts. One
explanation of this finding is that there are three different populations of cancer/background
dyads. One population of cancer/background dyads is film-detectible. The second population
of cancer/background dyads is digital-detectible. The third population cannot be detected on
either modality, either because the cancer has not developed yet or because it is invisible against
its background.
How big might the increase in detection due to using the combined modality be? We have no
data to answer this question. However, published sources of information can help us to guess
the size of the increase. We made several assumptions so that we could conduct a thought
experiment. First, we assumed that the Lewin trial (1) missed approximately 10% of the total
number of cancers, i.e. that 10% of the cancers were neither detected by film, nor by digital,
nor seen as interval cancers. Second, we extrapolated from the increased detection rate seen in
three double reader studies (Ciatto, Thurfjell and Antinnen, 12–14) to a double modality/
double reader study. This extrapolation led to the assumption that performing two digital
mammograms or two film mammograms would increase the overall number of cancers
detected by some 10%. Finally, we assumed that the proportion of interval cancers, and the
proportions of cancer/background dyads detectable by film mammography alone, digital
mammography alone, or both film and digital mammography occurred in the population at
roughly the rates seen in the Lewin trial (1).
These four populations are shown in Figure 3A. 3B shows that double screening and double
reading with film mammography will capture roughly the same cancers each time, resulting
in the detection of approximately 65% of all cancers. 3C shows similarly that double screening
and double reading with digital mammography will also capture roughly the same cancers each
time, resulting in the detection of approximately 55% all cancers. Notice that these cancers are
mostly from a different population of cancer/background dyads from those detected in 3B.
Finally, 3D shows that double screening, once with film and once with digital mammography,
should detect more cancers (roughly 75% of all cancers) since the combined modality has
greater efficacy in two different populations of cancer/background dyads. These numbers are
speculative (see assumptions described above), and only give an approximation of what this
trial might yield.
What we cannot know is what fraction of the cancers not detected by a given modality in the
Lewin trial are truly not detectable by that modality. In other words, what fraction of the
assumed 10% increase in cancer detection from a double film or double digital trial would
come from cancers seen only by the other modality in the Lewin trial, what fraction would
come from the interval cancers and what fraction would come from a presumed fourth
population of cancers present in the population but not detected by any means in the Lewin
trial.
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The trials described above would raise many ethical and monetary issues. Screening twice
increases the radiation dose to the breast. Double screening certainly increases the recall rate
and the biopsy rate, which leads to increased patient anxiety and morbidity. Double screening
will also increase cost. It is more expensive to acquire mammograms using two different
modalities than to acquire two different mammographic views. The breast screening clinics
would need to buy and maintain two machines, and there would be a large increase in the need
for radiologist time. Additionally, it will increase time, effort, and discomfort for the woman.
From the perspective of the insurer, double screening is too costly. From the perspective of a
clinician, double screening may seem too time-consuming. From the perspective of a patient,
however, the increased cancer detection rate may outweigh any other consideration. The
increase in the number of cancers detected by the combined modality in the Lewin (1) should
draw immediate patient and physician interest.
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ROC curves for Film Mammography Results, Digital Mammography Results and the
Combined Test Results in the Parametric Analysis.
Glueck et al. Page 8














Graph of AUC lines for ROC Nonparametric Analysis.
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Hypothetical Cancer Detection Results of Proposed Trial #2.
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Table 1
Proportions of Cancer Detected by Each Modality in Three Clinical Trials
Trial Screen film mammography Full field digital mammography Combined modalities
Lewin et al.(1) 32 / 49 = 65.3% 27 / 49 = 55.1% 41 / 49 = 83.7%
Skaane et al.* (2) 28 / 31 = 90.3% 23 / 31 = 74.2% 31 / 31 = 100%
Pisano et al. (3) 174 / 335 = 51.9% 185 / 335 = 55.2% 237 / 335 = 70.7%
*
No interval cancers were reported in this study
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Table 2
Parametric ROC Analysis Results
Statistics Film vs. Combined Digital Vs. Combined Film vs. Digital
First modality AUC 0.831 0.7956 0.8283
Standard Error 0.0406 0.0267 0.0423
Second modality AUC 0.8873 0.885 0.7865
Standard Error 0.0259 0.0509 0.0538
AUC difference 0.0563 0.0894 0.0418
Standard Error difference 0.03122 0.04467 0.06357
Z-score 1.8045 1.9996 0.6587
p-value 0.0712 0.0455 0.5101
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Table 3
Nonparametric ROC Analysis Results
Statistics Film vs. Combined Digital Vs. Combined Film vs. Digital
First modality AUC 0.7811 0.7377 0.7811
Standard Error 0.037 0.0381 0.037
Second modality AUC 0.8541 0.8541 0.7377
Standard Error 0.0315 0.0315 0.0381
AUC difference 0.073 0.1164 0.0434
Standard Error difference 0.0275 0.0347 0.0501
Chi squared (df = 1) 7.0397 11.281 0.7507
p-value 0.008 0.0008 0.3863
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